In this review, we describe current and future potential wound healing treatments for acute
and chronic wounds. The current wound healing approaches are based on autografts …

Mesenchymal stem cells (MSCs) can be isolated from almost all tissues and effectively
expanded in vitro. Although their true in situ properties and biological functions remain to be …

Diabetic foot ulcers (DFUs) are a chronic, non-healing complication of diabetes that lead to
high hospital costs and, in extreme cases, to amputation. Diabetic neuropathy, peripheral …

Cutaneous wound repair is a highly coordinated cascade of cellular responses to injury
which restores the epidermal integrity and its barrier functions. Even under optimal healing …

Mesenchymal stem cells (MSCs) are considered to hold great therapeutic value for cell-
based therapy and for tissue regeneration in particular. Recent evidence indicates that the …

Chronic diabetic wounds represent a huge socioeconomic burden for both affected
individuals and the entire healthcare system. Although the number of available treatment …

Diabetes has become a global public health problem. Diabetic foot is one of the most severe
complications of diabetes, which often places a heavy economic burden on patients and …

Cutaneous wound healing is a complex multiple phase process, which overlaps each other,
where several growth factors, cytokines, chemokines, and various cells interact in a well …

AIMS: To identify better cells for the treatment of diabetic critical limb ischemia (CLI) and foot
ulcer in a pilot trial. METHODS: Under ordinary treatment, the limbs of 41 type 2 diabetic …

Background Diabetic foot ulcer (DFU) is a severe complication of diabetes, preceding most
diabetes-related amputations. DFUs require over US $9 billion for yearly treatment and are …